Dorman T
Pharmatherapeutica. 1983;3(6):433-40.
A single-blind, parallel group, multi-centre study was carried out in 2009 patients with an anxiety state to compare the efficacy, tolerance and withdrawal effects of prazepam and diazepam in therapeutically equivalent doses. Patients were allocated at random to receive 30 mg prazepam or 15 mg diazepam per day, either in divided dosage (3 times) during the day or as a single large dose at night. After a 2-week treatment period, drug therapy was withdrawn gradually. Patients were followed-up at weekly intervals over the 4-week study period. Hamilton Anxiety Rating Scale scores and physicians' global assessment of response at each visit indicated that whilst both drugs and dosage regimens were effective patients treated with diazepam responded rather less well and had a greater return of anxiety symptoms after therapy was stopped compared to those on prazepam. Moreover, the prazepam-treated patients, especially those on the divided daytime dosage regimen, had fewer and milder side-effects in the early treatment period. Dizziness was least apparent in the prazepam single night time dosage group and it is suggested that this may be an important practical consideration in the treatment of anxiety in the elderly.
对2009例焦虑症患者进行了一项单盲、平行组、多中心研究,以比较等效治疗剂量下普拉西泮和地西泮的疗效、耐受性及撤药效应。患者被随机分配,分别每日接受30mg普拉西泮或15mg地西泮治疗,白天分剂量(3次)给药或夜间单次大剂量给药。经过2周的治疗期后,逐渐停用药物治疗。在为期4周的研究期间,每周对患者进行随访。汉密尔顿焦虑量表评分以及医生每次访视时对疗效的整体评估表明,虽然两种药物及给药方案均有效,但与接受普拉西泮治疗的患者相比,接受地西泮治疗的患者反应稍差,且在治疗停止后焦虑症状复发更为明显。此外,接受普拉西泮治疗的患者,尤其是采用白天分剂量给药方案的患者,在治疗早期出现的副作用更少、更轻微。头晕在普拉西泮夜间单次给药组中最不明显,提示这可能是老年焦虑症治疗中的一个重要实际考量因素。